Access Navigate offers distinct engagement models, each designed to provide targeted insights and strategic clarity at critical development milestones.
Payer Readiness Diagnostic
Payer Strategy Hypothesis
Payer Strategy Validation
Flexible Market Access Retainer
For preclinical, Phase 1, or Phase 2 companies needing an early read on price potential, reimbursement risk, and payer evidence gaps. Typical range USD ~$5,000 to $15,000.
For teams needing senior advisory to define payer strategy, build pricing and access assumptions, and outline an access roadmap. Typical range USD$25,000.
For targeted payer, clinician, or KOL input, value proposition testing, and refined payer strategy and access planning. Typical range USD $35,000 to $65,000.
For ongoing senior payer strategy support, ensuring continuous guidance and insights as your asset progresses. Typical range $2,800 to $15,000 per month.
Payer Strategy by Development Stage
Payer strategy evolves with your asset. We align our insights to your development stage, ensuring timely and relevant guidance.
Preclinical and Pre-Phase 1
Early read on price potential, reimbursement risk, payer evidence gaps, access barriers, and HTA risk to inform preclinical and Phase 1 decisions.
Pre-Phase 2
Define payer strategy, build pricing and access assumptions, review analogs, and estimate value-based price potential before Phase 2 clinical planning.
Pre-Phase 3
Targeted payer, clinician, or KOL input, value proposition testing, and refined payer strategy and access planning for Phase 3 readiness.
Pre-Launch
Develop an access roadmap, refine value story guidance, and prepare for launch sequencing and commercial diligence with payer insights.
BD / Financing / Diligence
Support for investor valuation, business development partnering, licensing, acquisition, and commercial diligence with robust payer strategy.
Find the right payer strategy engagement
Let's discuss your asset's unique needs and align on the advisory model that best supports your strategic milestones.